500257 announcements Lupin Ltd. announcements and dividends declared BSE
Lupin Ltd. Complete list of announcements declared & dividend announcements by Lupin Ltd. 500257
Lupin Ltd. 500257 listed on BSE and deals inAnnouncements and dividends declared by Lupin Ltd. 500257
Lupin rolls out generic oncology drug in US market
Drug firm Lupin has launched a generic cancer treatment medication in the US. The company introduced Dasatinib Tablets in various strengths. This product is bioequivalent to Sprycel Tablets. It is indicated for adults with Philadelphia chromosome-positive
Announcement as on 02 February 2026
Drug maker Lupin inks licensing pact with Galenicum for injectable Semaglutide
Drug maker Lupin announced a significant partnership. Its subsidiary, Lupin Atlantis Holdings SA, has signed an agreement with Galenicum Health. This collaboration focuses on diabetes and weight management medication, specifically injectable Semaglutide. G
Announcement as on 21 January 2026
Lupin inks licensing pact with Neopharmed for Plasil brand in Philippines, Brazil
Pharma major Lupin Limited has secured exclusive marketing rights for the gastroenterology brand Plasil in the Philippines and Brazil. Subsidiaries in these nations inked a deal with Italy's Neopharmed Gentili S.p.A. This move will boost Lupin's gastroente
Announcement as on 18 December 2025
Lupin gets USFDA nod for multiple sclerosis drug
Drug maker Lupin has secured approval from the US health regulator for its generic multiple sclerosis treatment. The company received tentative approval from the USFDA for Siponimod Tablets. This new product will be manufactured at Lupin's Pithampur facili
Announcement as on 05 December 2025
Lupin gets USFDA nod for biosimilar drug
Lupin gets USFDA approval for Armlupeg, a biosimilar to Neulasta, to treat neutropenia in cancer patients. The drug will be manufactured at Lupin’s Pune facility. Armlupeg aims to reduce infection risk from chemotherapy, and Lupin plans to expand its US bi
Announcement as on 01 December 2025
Announcements by Lupin Ltd. first page | Next page | Prev page |
500257 Lupin Ltd. current price & indicator signals
Recent prices of 500257 Lupin Ltd. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 22 Fri May 2026 | 2279.50 | 2270.00 to 2304.90 | -0.26% | 1.07 times |
| 21 Thu May 2026 | 2285.35 | 2270.15 to 2327.25 | 0.09% | 1 times |
| 20 Wed May 2026 | 2283.40 | 2268.10 to 2308.70 | -0.14% | 0.69 times |
| 19 Tue May 2026 | 2286.50 | 2250.70 to 2293.95 | 1.49% | 0.36 times |
| 18 Mon May 2026 | 2253.00 | 2216.45 to 2273.60 | -0.92% | 0.48 times |
| 15 Fri May 2026 | 2273.90 | 2255.00 to 2298.30 | 0.71% | 0.32 times |
| 14 Thu May 2026 | 2257.80 | 2225.80 to 2273.20 | 1.91% | 0.8 times |
| 13 Wed May 2026 | 2215.45 | 2210.80 to 2264.40 | -1.36% | 0.42 times |
| 12 Tue May 2026 | 2246.00 | 2233.10 to 2287.70 | 0.02% | 0.41 times |
| 11 Mon May 2026 | 2245.65 | 2236.80 to 2350.00 | -5.56% | 3.91 times |
| 08 Fri May 2026 | 2377.90 | 2347.45 to 2475.00 | -3.33% | 1.61 times |
| 07 Thu May 2026 | 2459.75 | 2431.05 to 2492.00 | 0.71% | 0.73 times |
Videos related to: 500257 announcements Lupin Ltd. announcements and dividends declared BSE
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- BSE Screeners
- BSE Daily Screener
- BSE Weekly Screener
- BSE Monthly Screener
- Support & Resistance
- BSE Shares Near Support
- BSE Shares Near Resistance


